METROPOLITAN LIFE INSURANCE CO/NY - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$33,967
-62.7%
4,698
-52.4%
0.00%
-100.0%
Q2 2021$91,100
-25.0%
9,8700.0%0.00%
-50.0%
Q1 2021$121,500
-15.6%
9,870
-3.3%
0.00%0.0%
Q4 2020$143,905
+17.5%
10,2060.0%0.00%0.0%
Q3 2020$122,472
-27.7%
10,2060.0%0.00%
-33.3%
Q2 2020$169,42010,2060.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 2,291,133$1,166,1871.01%
Privium Fund Management (UK) Ltd 117,200$59,6550.04%
Redmile Group, LLC 1,850,566$941,9380.04%
Baker Brothers Advisors 3,821,740$1,945,2660.01%
Kynam Capital Management, LP 120,764$61,4690.01%
Sio Capital Management, LLC 38,312$19,5010.01%
SIMON QUICK ADVISORS, LLC 46,856$23,8500.00%
Tri Locum Partners LP 10,248$5,0000.00%
Endurance Wealth Management, Inc. 20,000$100.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$38,1750.00%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders